Loading stock data...

SMS Pharmaceuticals Limited

NSE: SMSPHARMA BSE: SMSPHARMA

NSE
372.45 14.45 (4.04%)

Prev Close

358

Open Price

360

Volume

1,292,779

Today Low / High

354.7 / 387.5

52 WK Low / High

176.05 / 387.5

Range

354 - 391

BSE
372.90 14.95 (4.18%)

Prev Close

357.95

Open Price

358.65

Volume

30,431

Today Low / High

355.9 / 387

52 WK Low / High

175 / 387

Range

354 - 392

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 372.45 (target range: 354 - 391), reflecting a change of 14.45 (4.03631%). On the BSE, it is listed at 372.9 (target range: 354 - 392), showing a change of 14.95 (4.17656%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.

20 Feb 360.00 3.46%
19 Feb 360.90 -0.80%
18 Feb 367.50 0.60%
17 Feb 342.80 7.21%
16 Feb 335.00 1.55%
13 Feb 342.00 -1.42%
12 Feb 320.20 9.56%
11 Feb 318.80 0.05%
10 Feb 322.00 -1.09%
09 Feb 317.15 0.96%
06 Feb 320.75 -0.86%
05 Feb 320.65 -0.06%
04 Feb 316.20 1.91%
03 Feb 323.00 -2.69%
02 Feb 314.95 0.05%
01 Feb 319.90 -0.42%
30 Jan 304.85 3.85%
29 Jan 302.00 2.35%
28 Jan 299.55 1.17%
27 Jan 302.00 -0.84%

SMS Pharmaceuticals Limited Graph

SMS Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for SMS Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 372.45, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 372.90 376.63 338.97 - 414.29
380.36 304.29 - 456.43
384.09 268.86 - 499.31
Bearish Scenario 372.90 369.17 332.25 - 406.09
365.44 292.35 - 438.53
361.71 253.20 - 470.23

Overview of SMS Pharmaceuticals Limited

ISIN

INE812G01025

Industry

Drug Manufacturers - General

Vol.Avg

618,317

Market Cap

34,880,687,400

Last Dividend

0.4

Official Website

Visit Website

IPO Date

2007-02-28

DCF Diff

724.26

DCF

-352

Financial Ratios Every Investor Needs

Stock Dividend of SMSPHARMA

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-09-22 September 22, 25 0.4 0.4 2025-09-22 2025-10-29
2024-09-23 September 23, 24 0.4 0.4 2024-09-23 2024-10-30
2023-09-22 September 22, 23 0.3 0.3 2023-09-22 2023-10-29
2022-09-22 September 22, 22 0.3 0.3 2022-09-23 2022-10-30
2021-09-22 September 22, 21 0.3 0.3 2021-09-23 2021-10-30

Stock Rating Details for SMSPHARMA

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 782.75 Cr 637.83 Cr 144.92 Cr 0.1851 12.83 Cr 7.42 Cr 103.32 Cr 69.14 Cr 8.15 145.22 Cr 0.0883
2024-03-31 709.26 Cr 498.33 Cr 210.94 Cr 0.2974 11.11 Cr 64.22 Cr 134.01 Cr 49.83 Cr 5.89 117.53 Cr 0.0703
2023-03-31 522.05 Cr 393.13 Cr 128.92 Cr 0.2469 8.92 Cr 5.59 Cr 21.34 Cr -7.06 Cr -0.83 59.39 Cr -0.0135
2022-03-31 515.02 Cr 333.59 Cr 181.43 Cr 0.3523 8.39 Cr 4.95 Cr 78.98 Cr 62.22 Cr 7.35 119.53 Cr 0.1208
2021-03-31 560.82 Cr 379.39 Cr 181.43 Cr 0.3235 7.35 Cr 4.11 Cr 97.67 Cr 62.53 Cr 7.39 124.56 Cr 0.1115

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 41.59 Cr 1,152.68 Cr 513.04 Cr 639.6443 Cr 310.76 Cr 269.17 Cr 284.73 Cr 565.52 Cr 0.00 Cr 0.00 Cr 11.68 Cr 324.3686 Cr
2024-03-31 36.04 Cr 1,034.09 Cr 497.76 Cr 536.3289 Cr 280.77 Cr 244.73 Cr 233.70 Cr 478.74 Cr 0.00 Cr 0.00 Cr 10.94 Cr 331.7184 Cr
2023-03-31 7.38 Cr 879.61 Cr 419.08 Cr 460.5252 Cr 254.07 Cr 246.69 Cr 223.50 Cr 443.74 Cr 6.55 Cr 0.00 Cr 11.45 Cr 254.9135 Cr
2022-03-31 46.58 Cr 859.50 Cr 389.21 Cr 470.2886 Cr 263.27 Cr 216.69 Cr 251.10 Cr 447.63 Cr 1.25 Cr 0.00 Cr 21.53 Cr 196.4803 Cr
2021-03-31 40.42 Cr 812.21 Cr 401.68 Cr 410.5280 Cr 254.58 Cr 214.16 Cr 137.79 Cr 462.50 Cr 22.62 Cr 0.00 Cr 26.85 Cr 195.4294 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 64.5230 Cr -123.5956 Cr 64.4322 Cr -58.8568 Cr 5.3596 Cr 41.5861 Cr -123.3798 Cr 69.1356 Cr 30.4302 Cr -3.3861 Cr -51.0313 Cr
2024-03-31 50.1247 Cr -52.0720 Cr 30.6790 Cr -2.0353 Cr 28.7317 Cr 36.0395 Cr -52.1600 Cr 49.8260 Cr 27.5298 Cr -2.5396 Cr -10.1984 Cr
2023-03-31 22.4500 Cr -29.6861 Cr -31.9689 Cr -7.4707 Cr -39.2050 Cr 7.3778 Cr -29.9207 Cr 5.3491 Cr -7.7671 Cr -2.5396 Cr 27.5981 Cr
2022-03-31 40.2337 Cr -27.1530 Cr -6.9210 Cr 12.9863 Cr 6.1597 Cr 46.5828 Cr -27.2474 Cr 68.4991 Cr 9.4075 Cr -2.5395 Cr -113.3102 Cr
2021-03-31 90.4534 Cr -151.5923 Cr 92.0178 Cr -61.2956 Cr 30.8789 Cr 40.4231 Cr -151.7490 Cr 91.1198 Cr 98.1617 Cr 0.0000 Cr -8.5871 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 210.45 Cr 166.63 Cr 43.82 Cr 0.2082 33.63 Cr 23.47 Cr 2.59 47.40 Cr 0.1115
2025-09-30 242.43 Cr 165.56 Cr 76.87 Cr 0.3171 38.34 Cr 25.31 Cr 2.84 49.80 Cr 0.1044
2025-06-30 196.05 Cr 130.70 Cr 65.35 Cr 0.3333 29.62 Cr 20.49 Cr 2.31 39.96 Cr 0.1045
2025-03-31 248.20 Cr 208.59 Cr 39.61 Cr 0.1596 32.17 Cr 20.32 Cr 2.39 42.23 Cr 0.0819
2024-12-31 173.35 Cr 106.24 Cr 67.11 Cr 0.3871 24.51 Cr 18.24 Cr 2.15 35.34 Cr 0.1052

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 99.49 Cr 2.57 Cr 102.06 Cr 221.42 Cr 317.47 Cr 661.15 Cr 567.52 Cr 1,276.46 Cr 547.11 Cr
2025-06-30 0.00 Cr 0.00 Cr 41.59 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -639.64 Cr
2025-03-31 41.59 Cr 0.00 Cr 41.59 Cr 203.23 Cr 284.73 Cr 554.47 Cr 565.52 Cr 1,152.68 Cr 513.04 Cr
2024-12-31 0.00 Cr 0.00 Cr 9.07 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -563.55 Cr
2024-09-30 8.90 Cr 11.99 Cr 20.89 Cr 213.38 Cr 315.27 Cr 581.94 Cr 518.41 Cr 1,134.73 Cr 571.18 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 20.49 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 20.32 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 18.24 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 14.10 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 16.48 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2015-12-17 December 17, 15 10:1

Similar Stocks: Drug Manufacturers - General

Company Name Symbol Price Market Cap Volume
Cipla Limited CIPLA ₹1,341.10 ₹1,083,314,665,925.00 ₹1,551,704.00
Abbott India Limited ABBOTINDIA ₹26,295.00 ₹558,750,396,090.00 ₹7,694.00
GlaxoSmithKline Pharmaceuticals Limited GLAXO ₹2,596.90 ₹439,930,529,695.00 ₹39,078.00
Gland Pharma Limited GLAND ₹1,821.70 ₹300,136,775,779.00 ₹16,533.00
Pfizer Limited PFIZER ₹4,931.70 ₹225,614,089,904.00 ₹10,105.00
Sanofi Consumer Healthcare India Ltd. SANOFICONR ₹4,044.60 ₹93,149,653,741.00 ₹2,673.00
Sanofi India Limited SANOFI ₹4,026.10 ₹92,723,587,234.00 ₹7,749.00
Marksans Pharma Limited MARKSANS ₹178.38 ₹80,835,349,011.00 ₹438,114.00
Senores Pharmaceuticals Ltd. SENORES ₹810.30 ₹37,317,222,356.00 ₹76,440.00
SMS Pharmaceuticals Limited SMSPHARMA ₹372.45 ₹34,880,687,400.00 ₹1,292,779.00

Key Executives

Chief Financial Officer
Lakshmi Narayana Tammineedi

Gender: male

Year Born:

Vice President of Operations
Prasad

Gender: male

Year Born:

Head of HRD and General Manager of Purchases
Potluri Ravi Kumar

Gender: male

Year Born: 1962

Chairman & MD
Ramesh Babu Potluri

Gender: male

Year Born: 1958

Company Secretary & Compliance Officer
Tumma Thirumalesh

Gender: male

Year Born:

Executive Director
Vamsi Krishna Potluri

Gender: male

Year Born: 1988

Assistant General Manager of HR and Legal
Y. Nagarjuna Rao

Gender: male

Year Born: 1964

FAQs about SMS Pharmaceuticals Limited

Who is the CEO of the company?

The CEO is Ramesh Babu Potluri.

What is the current market price of the stock?

The current price is ₹372.45.

What is the 52-week price range?

The range is ₹176.05-387.5.

What is the market capitalization of the company?

The market capitalization is ₹3,488.07 crores.

What is the dividend yield?

The dividend yield is 0.11%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 37.68.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of SMS Pharmaceuticals Limited (ISIN: INE812G01025) is a leading Drug Manufacturers - General in India. With a market capitalization of ₹3,488.07 crores and an average daily volume of 618,317 shares, it operates in the Drug Manufacturers - General. The company last declared a dividend of ₹0.4.